68 filings
Page 3 of 4
8-K
xv5 5rrp3rojq
23 Feb 22
Regulation FD Disclosure
9:31am
8-K
3osp4
10 Feb 22
23andMe Reports FY2022 Third Quarter Financial Results
4:11pm
8-K
y2iw5twcinday
18 Jan 22
Regulation FD Disclosure
8:15am
8-K
5iqo 5m28rup
10 Jan 22
23andMe Receives FDA Clearance for Direct-to-Consumer Genetic Test on a Hereditary Prostate Cancer Marker
8:16am
8-K
51rvyh572m7756vgll
6 Jan 22
Regulation FD Disclosure
4:05pm
8-K
vi4dsqgq
28 Dec 21
23andMe Announces the Results of the Completed Redemption of All Outstanding Warrants
4:16pm
8-K
8al xkux7555
22 Nov 21
23andMe Announces Redemption of All Outstanding Warrants
4:31pm
8-K
qmv wlikrau
10 Nov 21
Results of Operations and Financial Condition
4:11pm
8-K
2f0hh9ycawnst45xw
9 Nov 21
23andMe Announces Appointment of Dr. Sandra Hernández to Board of Directors
4:06pm
8-K
yk0w g3ipk
2 Nov 21
23andMe Announces the Closing of its Acquisition of Lemonaid Health
8:02am
8-K
pca73wj63ma31a88
22 Oct 21
23andMe Agrees to Acquire Lemonaid Health
4:05pm
8-K
af2nc8 vk
10 Sep 21
Regulation FD Disclosure
7:02am
8-K
cg2vpqm3e be
13 Aug 21
23andMe Reports FY2022 First Quarter Financial Results
7:13am
8-K/A
kn052ey0sh5c6
21 Jun 21
Material Modifications to Rights of Security Holders
8:32am
8-K
h33mp3zb4mq2bx2wd
21 Jun 21
Index to Consolidated Financial Statements
8:31am
8-K
ofufgiuner
11 Jun 21
Departure of Directors or Certain Officers
5:28pm
8-K
eitlo8fry
4 Jun 21
Other Events
5:06pm
8-K
jt7u52 26o
28 May 21
VG Acquisition Corp. Receives Expected Notification from NYSE Related to Delayed Quarterly Report
5:15pm
8-K
phs8xc20
27 May 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
dhdgb
3 May 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:23pm